Dusa Pharmaceuticals, Inc. (DUSA) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $57.34 -0.59%
Financial Fact:
Loss on change in fair value of warrants: -1.7M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Loss on change in fair value of warrants: -1.7M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Dusa Pharmaceuticals, Inc. (NASDAQ: DUSA) reported Q3 EPS of $0.05, $0.05 better than the analyst estimate of $0.00. Revenue for the quarter came in at $9.4 million versus the consensus estimate of $8.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
